The fourth component, GHK-Cu, will be voted on in a subsequent February 2027 meeting HHS has announced that GHK-Cu is expected to return to Category 1 (after being moved to Category 2 in September 2023), which would restore compounding access for injectable formulations. The recommendations of the PCAC are non-binding but noteworthy
Oral B12 supplements must survive digestion, significantly reducing absorptionespecially for those with absorption issues
FormBlends operates in that supervised, prescription-first lane rather than shipping a research chemical with no oversight attached, and that structural fact holds the same whether the molecule on the table is 5-Amino-1MQ or a peptide like MOTS-c
Discard if there are signs of contamination, full discolouration, or moisture damage
As a result, many of the peptides potential benefits remain theoretical
Talanta 258, 124482